David Kirn - Net Worth and Insider Trading
David Kirn Net Worth
The estimated net worth of David Kirn is at least $6 Million dollars as of 2024-12-26. David Kirn is the CEO of 4D Molecular Therapeutics Inc and owns about 1,059,153 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $6 Million. Details can be seen in David Kirn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Kirn has not made any transactions after 2024-07-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Kirn
David Kirn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Kirn owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of David Kirn’s form 4 insider trades.
Insider Ownership Summary of David Kirn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2024-07-10 | director & Chief Executive Officer |
David Kirn Latest Holdings Summary
David Kirn currently owns a total of 1 stock. David Kirn owns 1,059,153 shares of 4D Molecular Therapeutics Inc (FDMT) as of July 10, 2024, with a value of $6 Million.
Latest Holdings of David Kirn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2024-07-10 | 1,059,153 | 5.81 | 6,153,679 |
Holding Weightings of David Kirn
David Kirn Form 4 Trading Tracker
According to the SEC Form 4 filings, David Kirn has made a total of 8 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 12,923 shares on July 10, 2024, which brought David Kirn around $290,638.
Insider Trading History of David Kirn
- 1
David Kirn Trading Performance
David Kirn Ownership Network
David Kirn Owned Company Details
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
David Kirn is the director & Chief Executive Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , Chief Medical Officer Robert Young Kim , and 10 percent owner Viking Global Investors Lp .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, David Kirn made 5 insider transaction in 4D Molecular Therapeutics Inc (FDMT) with a net sale of 225,853. Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 540,000 shares made by Viking Global Investors Lp , and a net sale of 24,552 shares made by Robert Young Kim .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
David Kirn Mailing Address
Above is the net worth, insider trading, and ownership report for David Kirn. You might contact David Kirn via mailing address: C/o 4d Molecular Therapeutics Inc., 5858 Horton Street #455, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
